Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.
about
A reduced-dose seasonal trivalent influenza vaccine is safe and immunogenic in adult and elderly patients in a randomized controlled trialCurrent advancements and potential strategies in the development of MERS-CoV vaccinesHuman Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.New technologies for influenza vaccines.Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal deliveryMacrophage- and neutrophil-derived TNF-α instructs skin langerhans cells to prime antiviral immune responsesVaccination in elite athletes.Local response to microneedle-based influenza immunization in the skin.Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system.Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes.Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults.Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age.Intradermal vaccination for infants and children.Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview.Mucosal adjuvants for influenza virus-like particle vaccine.Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccinesHead-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability.Mucosal and Systemic Immune Responses to Influenza H7N9 Antigen HA1-2 Co-Delivered Intranasally with Flagellin or Polyethyleneimine in Mice and Chickens.New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy.Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide.Vaccination in solid organ transplantation.The alphabet soup describing licensed influenza vaccines.Microneedle patch for immunization of immunocompromised hosts.Human studies with microneedles for evaluation of their efficacy and safety.
P2860
Q24623902-A08BEEDC-CA63-43EB-B5DD-FB8E7144AD2EQ27012578-A6F565E5-C76C-456C-9E00-EDC0932ACE69Q30389743-49570A62-E234-4EA0-AD89-AE27F903684EQ30411859-54E647D2-3751-4047-BAAB-559978F01CA1Q33603206-06E8ECA8-93D7-4043-B70D-9EE280DC9650Q34053805-1D820E6B-94E7-4A87-96B0-151C17E47371Q34227424-6ADAC39D-CBA1-4011-A257-205855AA80E3Q35826992-9B7AFBD9-D9ED-4802-B775-80B13327E9C8Q35952784-F1E5365A-E5C1-4BCE-BC81-FDD6FA734950Q36410040-DF0385C3-1CE4-42B2-B650-5392AD2C2753Q36552868-DF6EB4F8-3BB8-4FC1-BB1F-415A1EE8C90FQ36887912-22E03C51-F529-4C38-8307-C543C622B36EQ37264939-C7D8DEA2-E093-4B20-BAC5-7740D6A81795Q37375954-A61C8047-A547-4742-9DC1-A66A1B53CE79Q37404044-05E66D48-961A-41A0-823C-1794F07EFA05Q37478319-A75E6A69-CECA-4CF8-95CC-72365F73F1E7Q37478325-7B580699-9902-434B-ABDC-42CBF3015BE9Q37737532-72BCC9B3-A577-4764-935C-24829B2742C8Q38883770-CC99610F-C835-4535-9367-DD1FED3C5D16Q42061242-05F34C2C-91A6-45C6-BD57-65DABB0FF72DQ42272271-1C912B75-2D3C-4152-A187-9B1F8A244ADEQ43925796-C41F5B99-AF7C-4043-A92F-B1BC9D3B84C1Q47135944-27B273F6-225C-4238-A6D2-586CF67F50ECQ47821469-629935D8-26B2-477A-9F37-2A135F204912
P2860
Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Comparison of the immunogenici ...... cular route in healthy adults.
@ast
Comparison of the immunogenici ...... cular route in healthy adults.
@en
type
label
Comparison of the immunogenici ...... cular route in healthy adults.
@ast
Comparison of the immunogenici ...... cular route in healthy adults.
@en
prefLabel
Comparison of the immunogenici ...... cular route in healthy adults.
@ast
Comparison of the immunogenici ...... cular route in healthy adults.
@en
P2093
P2860
P1433
P1476
Comparison of the immunogenici ...... cular route in healthy adults.
@en
P2093
Christine M Hay
Cornelia L Dekker
Emmanuel B Walter
Heather Hill
James D Campbell
John Treanor
Mark Wolff
Nadia Tornieporth
Rebecca C Brady
Robert Belshe
P2860
P304
P356
10.1016/J.VACCINE.2011.06.010
P407
P577
2011-06-23T00:00:00Z